Westmount Partners, LLC

Position in GILD — Gilead Sciences, Inc.

CIK 2051491 LOS ANGELES, CA

Position in GILD

as of Jun 30, 2026 · filed Jul 7, 2026 Compact

Position Value

$364,743

-$31,485 QoQ

Shares Held

2,887

+1.5% QoQ

Ownership

0.000%

of shares outstanding

% of Portfolio

0.12%

of 13F equity value

Holder Rank

#1,545

of 2,266 holders

Holding Since

Dec 2022

15 quarters on record

Voting authority Sole 98% Shared 0% None 2%

Healthcare · as of Jun 30, 2026

Westmount Partners, LLC holds $10,104,775 across 9 Drug Manufacturers - General names. GILD ranks #7 (3.6% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	LLY	ELI LILLY & Co	2,289	$2,745,495
2	JNJ	Johnson & Johnson	9,734	$2,472,143
3	ABBV	AbbVie Inc.	5,727	$1,441,142
4	AMGN	Amgen Inc	3,735	$1,352,518
5	MRK	Merck & Co., Inc.	5,013	$644,170
6	BMY	Bristol Myers Squibb Co	10,185	$586,859
7	GILD	Gilead Sciences, Inc. This page	2,887	$364,743
8	PFE	Pfizer Inc	10,594	$255,103

15 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-06-30	$364,743	2,887	+1.5%	Shares	Sole	2026-07-07
2026-03-31	$396,228	2,843	+0.3%	Shares	Sole	2026-04-16
2025-12-31	$347,845	2,834	-9.0%	Shares	Sole	2026-01-15
2025-09-30	$345,654	3,114	+0.1%	Shares	Sole	2025-10-14
2025-06-30	$344,805	3,110	+0.3%	Shares	Sole	2025-07-09
2025-03-31	$347,355	3,100	-6.4%	Shares	Sole	2025-05-01
2024-12-31	$306,021	3,313	+7.9%	Shares	Sole	2025-01-13
2024-09-30	$257,388	3,070	+0.2%	Shares	Sole	2025-01-13
2024-06-30	$210,289	3,065	+0.2%	Shares	Sole	2025-01-28
2024-03-31	$224,071	3,059	-4.3%	Shares	Sole	2025-01-28
2023-12-31	$258,907	3,196	-3.2%	Shares	Sole	2025-01-28
2023-09-30	$247,526	3,303	+8.5%	Shares	Sole	2025-01-28
2023-06-30	$234,524	3,043	-3.0%	Shares	Sole	2025-01-28
2023-03-31	$260,359	3,138	-3.6%	Shares	Sole	2025-01-29
2022-12-31	$279,441	3,255	—	Shares	Sole	2025-01-28
No filing history on record for this holder in this stock.